PHF TAU IN NEURODEGENERATIVE DISEASE IN MICRONESIA
PHF TAU IN NEURODEGENERATIVE DISEASE IN MICRONESIA
批准号:
6267709
负责人:
VIRGINIA M LEE
金额:
$18.57万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-03-01 至 1999-02-28
中文摘要
类似阿尔茨海默氏症的神经退行性疾病的患病率
疾病(AD)、帕金森病(PD)和肌萎缩侧索硬化症
在马里亚纳群岛的查莫罗人中,肌萎缩侧索硬化症的发病率异常高。尽管
这些查莫罗病(称为关岛ALSIPDC)和
AD、PD或ALS在其他地方,关岛ALS/PDC脑中的主要发现
有丰富的神经原纤维缠结(NE;TS),就像经典的AD一样。
例如,NFTs AD和关岛ALS/PDC的主要结构要素
是成对螺旋丝(PHF),以前的研究表明
AD和关岛ALSIPDC的PHF是由异常形成的
磷酸化tau蛋白(PHFtau)。尽管如此,我们还是做了活检
衍生的正常成人tau在几乎所有的
以前在公元前PHFtau发现的地点,尽管程度较小,
活体组织来源的正常人tau经历快速和选择性
在PHFtau中异常保留的位点上的去磷酸化。我们
也提供了数据,表明磷酸化的差异
正常人类tau与PHFtau的状态可能是由于受损
阿尔茨海默病患者脑组织中的磷酸酶活性。事实上,蛋白磷酸酶2A
(PP2A)被牵连到PHFtau未能有效地接受
去磷酸化。由于PP2A使tau去磷酸化,因此
PP2A的辅助、催化和调节亚基可能发挥作用
在PHFtau的产生中起着核心作用。尽管地球的退化
关岛ALSIPDC中的神经元几乎完全与
脑脊液中NFTs的蓄积和棕褐色的水平
AD患者脑脊液(CSF)较对照组升高,其发病机制
PHFtau的积累及其生物学意义
阿尔茨海默病和关岛ALS/PDC中的神经纤维损害知之甚少。
因此,项目4将测试富含PHFtau的假设
神经原纤维损伤在神经细胞退行性变中起作用
关岛ALS/PDC。为了做到这一点,我们将评估生物
脑脊液tan水平升高的意义,检测PP2A在脑脊液中的作用
PHFtau和缠结形成的发病机制,并描述了
大脑中承载缠结的神经元与正常神经元的分子图谱
患有和不患有关岛ALS/PDC的患者。这些研究将提供
对PHFtau发病机制的重要认识
关岛ALS/PDC的损害,并阐明这些损害如何导致神经元
在关岛ALS/PDC的损失。
英文摘要
The prevalence of neurodegenerative disorders similar to Alzheimer's
disease (AD), Parkinson's disease (PD) and Amyotrophic Lateral Sclerosis
(ALS) is unusually high among Chamorros in the Mariana Islands. Despite
similarities between these Chamorro diseases (known as Guam ALSIPDC) and
AD, PD or ALS elsewhere, the predominant findings in Guam ALS/PDC brains
are abundant neurofibrillary tangles (NE;Ts) like those in classic AD.
For example, the major structural elements of NFTs AD and Guam ALS/PDC
are paired helical filaments (PHFs), and previous studies showed that
the PHFs in AD and Guam ALSIPDC are formed from abnormally
phosphorylated tau proteins (PHFtau). Although, we showed that biopsy
derived normal adult human tau is phosphorylated at nearly all of the
sites previously identified in AD PHFtau, albeit to a lesser extent,
biopsy derived normal human tau undergoes rapid and selective
dephosphorylation at sites that are abnormally retained in PHFtau. We
also provided data to suggest that differences in the phosphorylation
state of normal human tau versus PHFtau may be due to impaired
phosphatase activity in the AD brain. Indeed, protein phosphatase 2A
(PP2A) was implicated in the failure of PHFtau to undergo efficient
dephosphorylation. Since PP2A dephosphorylates tau, alterations in the
accessory, catalytic and regulatory subunits of PP2A could play a
central role in the generation of PHFtau. Although the degeneration of
neurons in Guam ALSIPDC is associated almost exclusively with the
accumulation of NFTs, and the levels of tan in the cerebrospinal fluid
(CSF) of AD patients are elevated relative to controls, the pathogenesis
and biological significance of accumulations of PHFtau in
neurofibrillary lesions in AD and Guam ALS/PDC are poorly understood.
Thus, Project 4 will test the hypothesis that PHFtau-rich
neurofibrillary lesions play a role in the degeneration of neurons in
Guam ALS/PDC. To accomplish this, we will assess the biological
significance of elevated levels of CSF tan, examine the role of PP2A in
the pathogenesis of PHFtau and tangle formation, and characterize the
molecular profile of tangle bearing versus normal neurons in the brains
of patients with and without Guam ALS/PDC. These studies will provide
important insights into the pathogenesis of PHFtau in the hallmark
lesions of Guam ALS/PDC, and clarify how these lesions lead to neuron
loss in Guam ALS/PDC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathogenesis of Tauopathies
-
批准号:10583338
-
项目类别:
-
资助金额:$75.43万
-
财政年份:2023
-
负责人:VIRGINIA M LEE
-
依托单位:
Project I "Mechanisms of Pathological aSyn Transmission"
-
批准号:10373920
-
项目类别:
-
资助金额:$45.27万
-
财政年份:2019
-
负责人:VIRGINIA M LEE
-
依托单位:
Center On Alpha-synuclein Strains In Alzheimer Disease & Related Dementias
-
批准号:10654792
-
项目类别:
-
资助金额:$362.24万
-
财政年份:2019
-
负责人:VIRGINIA M LEE
-
依托单位:
Project I "Mechanisms of Pathological aSyn Transmission"
-
批准号:10452562
-
项目类别:
-
资助金额:$67.03万
-
财政年份:2019
-
负责人:VIRGINIA M LEE
-
依托单位:
Project I "Mechanisms of Pathological aSyn Transmission"
-
批准号:10020334
-
项目类别:
-
资助金额:$52.07万
-
财政年份:2019
-
负责人:VIRGINIA M LEE
-
依托单位:
Center On Alpha-synuclein Strains In Alzheimer Disease & Related Dementias
-
批准号:10452557
-
项目类别:
-
资助金额:$362.24万
-
财政年份:2019
-
负责人:VIRGINIA M LEE
-
依托单位:
Examining neuronal resilience in a mouse model of sporadic ALS
-
批准号:10610826
-
项目类别:
-
资助金额:$35.22万
-
财政年份:2019
-
负责人:VIRGINIA M LEE
-
依托单位:
Center On Alpha-synuclein Strains In Alzheimer Disease & Related Dementias
-
批准号:10373915
-
项目类别:
-
资助金额:$362.15万
-
财政年份:2019
-
负责人:VIRGINIA M LEE
-
依托单位:
Project I "Mechanisms of Pathological aSyn Transmission"
-
批准号:10654801
-
项目类别:
-
资助金额:$52.23万
-
财政年份:2019
-
负责人:VIRGINIA M LEE
-
依托单位:
Examining neuronal resilience in a mouse model of sporadic ALS
-
批准号:10381720
-
项目类别:
-
资助金额:$35.22万
-
财政年份:2019
-
负责人:VIRGINIA M LEE
-
依托单位:
TDP-43 Proteinopathies in ALS-Dementia
-
批准号:8534672
-
项目类别:
-
资助金额:$109.35万
-
财政年份:2010
-
负责人:VIRGINIA M LEE
-
依托单位:
TDP-43 Proteinopathies in ALS-Dementia
-
批准号:8723014
-
项目类别:
-
资助金额:$115.72万
-
财政年份:2010
-
负责人:VIRGINIA M LEE
-
依托单位:
TDP-43 Proteinopathies in ALS-Dementia
-
批准号:8144829
-
项目类别:
-
资助金额:$116.68万
-
财政年份:2010
-
负责人:VIRGINIA M LEE
-
依托单位:
TDP-43 Proteinopathies in ALS-Dementia
-
批准号:7763551
-
项目类别:
-
资助金额:$118.74万
-
财政年份:2010
-
负责人:VIRGINIA M LEE
-
依托单位:
TDP-43 Proteinopathies in ALS-Dementia
-
批准号:8318125
-
项目类别:
-
资助金额:$115.72万
-
财政年份:2010
-
负责人:VIRGINIA M LEE
-
依托单位:
CORE--NEUROSCIENCE CORE
-
批准号:7492145
-
项目类别:
-
资助金额:$29.56万
-
财政年份:2007
-
负责人:VIRGINIA M LEE
-
依托单位:
NOVEL AB FRAGMENTS AS MEDIATORS OF ALZHEIMERS DISEASE
-
批准号:7492141
-
项目类别:
-
资助金额:$21.61万
-
财政年份:2007
-
负责人:VIRGINIA M LEE
-
依托单位:
Administrative Core
-
批准号:7498191
-
项目类别:
-
资助金额:$6.3万
-
财政年份:2007
-
负责人:VIRGINIA M LEE
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:6870600
-
项目类别:
-
资助金额:$6.57万
-
财政年份:2005
-
负责人:VIRGINIA M LEE
-
依托单位:
Biochemical and Immunohistochemical Analysis of FTDs
-
批准号:6851877
-
项目类别:
-
资助金额:$31.32万
-
财政年份:2005
-
负责人:VIRGINIA M LEE
-
依托单位:
海外基金